Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A
Clinical trial NCT04323098 · COMPLETED
Trial details
- NCT number
- NCT04323098
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-08
- Primary completion
- 2023-01-27
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.